Saturday 17 October 2026
Export HYPD’s income statement to Excel — free account
Hyperion DeFi, Inc.
HYPD Healthcare Biotechnology
Hyperion DeFi, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $813,500.00, up 1,319.7% from fiscal 2024. In the quarter to June 2026, revenue grew 2,333.3%, EPS grew 140.4%, free cash flow grew 86.8% and total debt rose 12.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.84
0.31
−9.84%
Follow HYPD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | — | — | 5 |
P/E ratio |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 0.00 | 6.58 | — | 6.60 | 169.80 | 21.15 |
Altman Z-Score |
— | — | — | — | (0.41) | 1.15 | — | (6.94) | (122.38) | (8.37) |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | (7.56) | (7.89) | — | (19.39) | (287.46) | (16.62) |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | — | 33.40 | — | — | — | — |
P/Operating CF |
— | — | — | — | 23.33 | (17.92) | — | (12.53) | (1.59) | (4.39) |
P/B ratio |
— | — | — | — | 8.34 | 5.15 | — | 8.80 | 0.00 | 0.43 |
Price to Tangible BV |
— | — | — | — | 8.34 | 5.15 | — | 11.52 | 0.00 | 0.87 |
EV/Sales |
— | — | — | — | 0.00 | 6.25 | — | 6.40 | 252.79 | 33.94 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (15.61) | (4.79) | — | (3.22) | (0.48) | (1.93) |
EV/FCF |
— | — | — | — | (15.00) | (4.45) | — | (2.88) | (0.48) | (0.36) |
Quick Ratio |
7.99 | 9.50 | 6.37 | 4.89 | 1.72 | 1.90 | 5.33 | 1.57 | 0.13 | 2.39 |
Current Ratio |
8.00 | 9.57 | 6.41 | 4.93 | 1.83 | 1.97 | 6.13 | 2.17 | 0.17 | 2.68 |
Net Debt/EBITDA |
0.96 | 1.03 | 1.14 | 0.66 | 1.42 | 0.97 | 0.55 | 0.25 | (0.06) | (0.03) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 1.37% | 22.65% | 27.57% | 31.12% | 129.13% | 15.06% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.35 | 0.50 | 1.00 | (0.36) | 0.19 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.43 | 0.00 | 0.00 | 0.00 | 0.03 |
Operating CF/Net income |
0.91 | 0.92 | 0.76 | 0.89 | 0.32 | 1.63 | 0.90 | 0.87 | 0.60 | 0.31 |
Capex/Depreciation |
(3.37) | (0.40) | (1.46) | (10.89) | (2.74) | (5.58) | (1.22) | (2.71) | (0.09) | 0.00 |
Interest Coverage |
(2,356.60) | (2,138.50) | (5,229.21) | (140.37) | (1,164.07) | (33.58) | (19.50) | (10.71) | (19.62) | (29.99) |
| (130.70%) | (126.68%) | (157.09%) | (147.87%) | (146.20%) | (71.45%) | (148.60%) | (207.83%) | 2,432.00% | (336.14%) | |
| (113.05%) | (113.04%) | (134.48%) | (121.90%) | (81.35%) | (38.98%) | (89.36%) | (91.15%) | (307.07%) | (169.57%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (99.54%) | (574.56%) | (511.04%) | 0.00% | (68.85%) |
Return on Tangible Assets |
(117.42%) | (107.73%) | (102.70%) | (181.32%) | (126.82%) | (105.60%) | (114.68%) | (187.35%) | 375.17% | (1,034.13%) |
Average Days of Receivables |
— | — | — | 0.00 | 541.30 | 47.06 | 0.00 | 11,891.32 | 157.98 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 668.17% | 106.08% | 0.00% | 341,468.42% | 25,240.31% | 234.84% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 381.30% | 75.50% | 0.00% | 326,800.00% | 25,014.14% | 2,111.33% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.40 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 124.16% | 20.62% | 0.00% | 65,734.21% | 2,974.35% | 783.28% |
Graham Net Nets |
— | — | — | — | 0.12 | 0.10 | — | 0.01 | (1.44) | (0.19) |
Graham Number |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 144.88 | 0.00 |
Earnings Yield |
— | — | — | — | (15.84%) | (12.50%) | — | (34.72%) | (508.05%) | (325.56%) |
Free Cash Flow Yield |
— | — | — | — | (5.21%) | (21.36%) | — | (33.70%) | (311.25%) | (451.70%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 7.60 | 42.54 | 0.00 | 0.01 | 0.07 | 0.16 |
Operating CF per Share |
(113.20) | (161.47) | (110.64) | (105.46) | (24.26) | (63.43) | (59.69) | (46.47) | (36.16) | (2.95) |
Capex per Share |
(1.52) | (0.35) | (0.24) | (0.93) | (0.99) | (4.92) | (2.08) | (7.74) | (0.19) | 0.00 |
Free Cash Flow per Share |
(114.72) | (161.82) | (110.88) | (106.39) | (25.25) | (68.35) | (61.77) | (54.22) | (36.35) | (2.95) |
Cash per Share |
119.69 | 179.16 | 166.48 | 78.89 | 107.80 | 59.14 | 54.36 | 28.95 | 2.55 | 1.29 |
Shareholders Equity per Share |
106.33 | 173.74 | 142.41 | 65.44 | 58.15 | 62.19 | 40.98 | 17.55 | (15.72) | 8.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
106.33 | 173.74 | 142.41 | 65.44 | 58.15 | 62.19 | 40.98 | 17.55 | (15.72) | 8.21 |
Free Cash Flow |
(3.25) | (4.74) | (13.14) | (19.09) | (6.65) | (22.49) | (25.98) | (27.81) | (30.28) | (14.77) |
Working Capital |
2.97 | 4.73 | 16.76 | 11.44 | 15.19 | 10.83 | 23.13 | 11.18 | (13.28) | 4.54 |
Capital Expenditures |
(0.04) | (0.01) | (0.03) | (0.17) | (0.26) | (1.62) | (0.87) | (3.97) | (0.16) | — |
Net Current Asset Value |
2.97 | 4.73 | 16.72 | 11.39 | 14.79 | 10.81 | 13.84 | 0.93 | (14.00) | (3.46) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.12 | 0.00 | 1,044.87 | 2.82 | 0.00 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.91 | 0.52 | 0.07 | 0.24 | 0.23 | 0.56 | 0.43 | 0.00 | 0.00 |
Cash ROIC |
(50.76%) | (45.85%) | (35.90%) | (73.71%) | (15.06%) | (47.76%) | (53.40%) | (84.76%) | 485.42% | (26.71%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 1.31 | 5.87 | 0.00 | 0.01 | 0.77 | 0.00 |
Accounts Payable Turnover |
0.05 | 0.09 | 0.02 | 0.01 | 0.53 | 1.04 | 0.20 | 0.01 | 2.12 | 0.27 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
8,611.72 | 3,526.90 | 28,846.47 | 36,771.96 | 666.90 | 368.22 | 1,695.93 | 39,994.88 | 181.67 | 382.57 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,504.81 | 0.00 | 0.00 |
Average Receivables |
— | — | — | 1.61 | 1.53 | 2.39 | 1.49 | 0.65 | 0.07 | — |
Average Payables |
0.27 | 0.27 | 0.88 | 1.53 | 1.50 | 1.54 | 1.52 | 1.59 | 1.85 | 1.14 |
Average Assets |
3.13 | 4.54 | 12.83 | 17.36 | 24.30 | 32.78 | 31.35 | 29.91 | 16.22 | 27.72 |
Average Common Equity |
2.70 | 4.05 | 10.98 | 14.31 | 13.52 | 17.89 | 18.85 | 13.12 | (2.05) | 13.98 |
Columns are period end dates